Macrolide-resistant Streptococcus pyogenes from Chinese pediatric patients in association with Tn916 transposons family over a 16-year period

Diagnostic Microbiology and Infectious Disease

Volumn 67, Issue 4, 2010, Pages 369-375

  Feng, Lijuan ^a   Lin, Hongrui ^a   Ma, Yaoling ^a   Yang, Yonghong ^a   Zheng, Yaojie ^b   Fu, Zhou ^c   Yu, Sangjie ^a   Yao, Kaihu ^a   Shen, Xuzhuang ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b SHENZHEN CHILDREN'S HOSPITAL   (China)

^c CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Macrolide resistance, ermB gene, Tn916 family; Streptococcus pyogenes

Indexed keywords

AZITHROMYCIN; BACTERIAL PROTEIN; CEFTAZIDIME; CHLORAMPHENICOL; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; JOSAMYCIN; MACROLIDE; OFLOXACIN; PENICILLIN G; PROTEIN ERMB; PROTEIN ERMTR; PROTEIN MEFA; PROTEIN TETM; TELITHROMYCIN; TETRACYCLINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BACTERIAL ANTIGEN; BACTERIAL DNA; CARRIER PROTEIN; OUTER MEMBRANE PROTEIN; STREPTOCOCCAL M PROTEIN; TRANSPOSON;

AGAR DIFFUSION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHINESE; CONTROLLED STUDY; GENE IDENTIFICATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEDIATRICS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; STREPTOCOCCUS PYOGENES; TRANSPOSON; ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; BACTERIAL GENE; BACTERIUM IDENTIFICATION; CHILD; CHINA; CLUSTER ANALYSIS; DNA FINGERPRINTING; DRUG EFFECTS; GENETICS; GENOTYPE; HUMAN; INFANT; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PRESCHOOL CHILD; PULSED FIELD GEL ELECTROPHORESIS; STREPTOCOCCUS INFECTION;

ADOLESCENT; ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; ASIAN CONTINENTAL ANCESTRY GROUP; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL TYPING TECHNIQUES; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; CHINA; CLUSTER ANALYSIS; DNA FINGERPRINTING; DNA TRANSPOSABLE ELEMENTS; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; GENES, BACTERIAL; GENOTYPE; HUMANS; INFANT; MACROLIDES; MICROBIAL SENSITIVITY TESTS; PEDIATRICS; POLYMERASE CHAIN REACTION; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 77954732508     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.03.014     Document Type: Article

References (37)

1. Alos J.I., Aracil B., Oteo J., Gomez-Garces J.L. Significant increase in the prevalence of erythromycin-resistant, clindamycin- and miocamycin-susceptible (M phenotype) Streptococcus pyogenes in Spain. J. Antimicrob. Chemother. 2003, 51:333-337.
2. Bandak S.I., Turnak M.R., Allen B.S., Bolzon L.D., Preston D.A. Oral antimicrobial susceptibilities of Streptococcus pyogenes recently isolated in five countries. Int. J. Clin. Pract. 2000, 54:585-588.
3. Biedenbach D.J., Stephen J.M., Jones R.N. Antimicrobial susceptibility profile among beta-haemolytic Streptococcus spp. collected in the SENTRY Antimicrobial Surveillance Program-North America, 2001. Diagn. Microbiol. Infect. Dis. 2003, 46:291-294.
4. Bingen E., Fitoussi F., Doit C., Cohen R., Tanna A., George R., Loukil C., Brahimi N., Le Thomas I., Deforche D. Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients. Antimicrob. Agents Chemother. 2000, 44:1453-1457.
5. Brenciani A., Bacciaglia A., Vecchi M., Vitali L.A., Varaldo P.E., Giovanettil E. Genetic elements carrying erm(B) in Streptococcus pyogenes and association with tet(M) tetracycline resistance gene. Antimicrob. Agents Chemother. 2007, 51:1209-1216.
6. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing. 18th Informational Supplement (M100-S18) 2008, CLSI, Wayne PA.
7. Cochetti I., Tili E., Vecchi M., Manzin A., Mingoia M., Varaldo P.E., Montanari M.P. New Tn916-related elements causing erm(B)-mediated erythromycin resistance in tetracycline-susceptible pneumococci. J. Antimicrob. Chemother. 2007, 60:127-131.
8. Cornaglia G., Ligozzi M., Mazzariol A., Masala L., Lo Cascio G., Orefici G., Fontana R. Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy. Clin. Infect. Dis. 1998, 27:S87-S92.
9. Creti R., Imperi M., Baldassarri L., Pataracchia M., Recchia S., Alfarone G., Orefici G. emm types, virulence factors, and antibiotic resistance of invasive Streptococcus pyogenes isolates from Italy: what has changed in 11 years?. J Clin Microbiol 2007, 45:2249-2256.
10. Dicuonzo G., Fiscarelli E., Gherardi G., Lorino G., Battistoni F., Landi S., De Cesaris M., Petitti T., Beall B. Erythromycin-resistant pharyngeal isolates of Streptococcus pyogenes recovered in Italy. Antimicrob. Agents Chemother. 2002, 46:3987-3990.
11. Douthwaite S., Jalava J., Jakobsen L. Ketolide resistance in Streptococcus pyogenes correlates with the degree of rRNA dimethylation by Erm. Mol. Microbiol. 2005, 58:613-622.
12. Drago L., Ripa S., Zampaloni C., De Vecchi E., Vitali L.A., Petrelli D., Prenna M. Activity of ceftibuten, cefaclor, azithromycin, clarithromycin, erythromycin and telithromycin against Streptococcus pyogenes clinical isolates with different genotypes and phenotypes. Chemotherapy 2005, 51:268-271.
13. Efstratiou A. Group A streptococci in the 1990s. J. Antimicrob. Chemother. 2000, 45:3-12.
14. Gagliotti C., Nobilio L., Milandri M., Moro M.L. Macrolide prescriptions and erythromycin resistance of Streptococcus pyogenes. Clin. Infect. Dis. 2006, 42:1153-1156.
15. Giovanetti E., Montanari M.P., Mingoia M., Varaldo P.E. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains. Antimicrob. Agents Chemother. 1999, 43:1935-1940.
16. Granizo J.J., Aguilar L., Casal J., Dal-Re R., Baquero F. Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997). J. Antimicrob. Chemother. 2000, 46:959-964.
17. Green N.M., Beres S.B., Graviss E.A., Allison J.E., Mcgeer A.J., Vuopio-Varkila J., LeFebvre R.B., Musser J.M. Genetic diversity among type emm28 group A Streptococcus strains causing invasive infections and pharyngitis. J. Clin. Microbiol. 2005, 43:4083-4091.
18. Gur D., Mulazimoglu L., Unal S. In vitro susceptibility of respiratory isolates of Streptococcus pneumoniae and Streptococcus pyogenes to telithromycin and 11 other antimicrobial agents: Turkish results of E-Baskett-II Surveillance Study. Mikrobiyol. Bul. 2007, 41:1-9.
19. Kaplan E.L., Johnson D.R., Del Rosario M.C., Horn D.L. Susceptibility of group A beta-hemolytic streptococci to thirteen antibiotics: examination of 301 strains isolated in the United States between 1994 and 1997. Pediatr. Infect. Disease J. 1999, 18:1069-1072.
20. Liang Y.M., Shen X.Z., Huang G.Y., Wang C.Q., Shen Y., Yang Y.H. Characteristics of Streptococcus pyogenes strains isolated from Chinese children with scarlet fever. Acta Paediatr. 2008, 97:1681-1685.
21. Liu X.R., Shen X.Z., Chang H.S., Huang G.Y., Fu Z., Zheng Y.J., Wang L.B., Li C.R., Liu L., Shen Y., Yang Y.G. High macrolide resistance in Streptococcus pyogenes strains isolated from children with pharyngitis in China. Pediatr. Pulmonol. 2009, 44:436-441.
22. Ma Y., Yang Y., Huang M., Wang Y., Chen Y., Deng L., Yu S., Deng Q., Zhang H., Wang C., Liu L., Shen X. Characterization of emm types and superantigens of Streptococcus pyogenes isolates from children during two sampling periods. Epidemiol. Infect. 2009, 137:1414-1419.
23. Michos A.G., Bakoula C.G., Braoudaki M., Koutouzi F.I., Roma E.S., Pangalis A., Nikolopoulou G., Kirikou E., Syriopoulou V.P. Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types. Diagn Microbiol Infect Dis 2009, 64:295-299.
24. McGregor K.F., Spratt B.G. Identity and prevalence of multilocus sequence typing-defined clones of group A streptococci within a hospital setting. J. Clin. Microbiol. 2005, 43:1963-1967.
25. Perez-Trallero E., Montes M., Orden B., Tamayo E., Garcia-Arenzana J.M., Marimon J.M. Phenotypic and genotypic characterization of Streptococcus pyogenes isolates displaying the MLSB phenotype of macrolide resistance in Spain, 1999 to 2005. Antimicrob. Agents Chemother. 2007, 51:1228-1233.
26. Reinert R.R., Lutticken R., Bryskier A., Al-Lahham A. Macrolide-resistant Streptococcus pneumoniae and Streptococcus pyogenes in the pediatric population in Germany during 2000-2001. Antimicrob. Agents Chemother. 2003, 47:489-493.
27. Richter S.S., Heilmann K.P., Beekmann S.E., Miller N.J., Miller A.L., Rice C.L., Doern C.D., Reid S.D., Doern G.V. Macrolide-resistant Streptococcus pyogenes in the United states, 2002-2003. Clin. Infect. Dis. 2005, 41:599-608.
28. Ripa S., Zampaloni C., Vitali L.A., Giovanetti E., Montanari M.P., Prenna M., Varaldo P.E. SmaI macrorestriction analysis of Italian isolates of erythromycin-resistant Streptococcus pyogenes and correlations with macrolide-resistance phenotypes. Microbial Drug Resistance-Mechanisms Epidemiology and Disease 2001, 7:65-71.
29. Robinson D.A., Sutcliffe J.A., Tewodros W., Manoharan A., Bessen D.E. Evolution and global dissemination of macrolide-resistant group a Streptococci. Antimicrob. Agents Chemother. 2006, 50:2903-2911.
30. Seppala H., Klaukka T., VuopioVarkila J., Muotiala A., Helenius H., Lager K., Huovinen P., Kontiainen S., Eskola J., Korpela J., KostialaThompson A., Sarkkinen H., Schauman K., Sivonen A., Vaara M., Eerola E., Hiekkaniemi H., Jarvinen H., Klossner M.L., Lehtonen O.P., Meurman O., Oinonen S., Katila M.L., Karkkainen P., Liimatainen O., Vuento R., Nissinen A., Hirvonen P., Kauppinen M., Kirsi O., Larinkari U., Ahonen E., Herva E., Jagerroos H., Koskela M., Lantto K., Ruuska P. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group a streptococci in Finland. N. Engl. J. Med. 1997, 337:441-446.
31. Steer A.C., Law I., Matatolu L., Beall B.W., Carapetis J.R. Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect. Dis. 2009, 9:611-616.
32. Szczypa K., Sadowy E., Izdebski R., Strakova L., Hryniewicz W. Group a streptococci from invasive-disease episodes in Poland are remarkably divergent at the molecular level. J. Clin. Microbiol. 2006, 44:3975-3979.
33. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel-electrophoresis-criteria for bacterial strain typing. J. Clin. Microbiol. 1995, 33:2233-2239.
34. Uh Y., Jang I.H., Hwang G.Y., Lee M.K., Yoon K.J., Kim H.Y. Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea. Antimicrob. Agents Chemother. 2004, 48:2716-2718.
35. Varaldo P.E., Montanari M.P., Giovanetti E. Genetic elements responsible for erythromycin resistance in streptococci. Antimicrob. Agents Chemother. 2009, 53:343-353.
36. Zampaloni C., Cappelletti P., Prenna M., Vitali L.A., Ripa S. emm gene distribution among erythromycin-resistant and -susceptible Italian isolates of Streptococcus pyogenes. J. Clin. Microbiol. 2003, 41:1307-1310.
37. Zhang W.S., Shen X.Z., Wang Y., Chen Y., Huang M., Zeng Q.Y., Wei J.H., Lu Q., Wang G., Deng L., Wang X.H., Yao K.H., Yu S.J., Yang Y.H. Antibiotic use in five children's hospitals during 2002-2006: the impact of antibiotic guidelines issued by the Chinese Ministry of Health. Pharmacoepidemiol. Drug Saf. 2008, 17:306-311.